CERo Therapeutics Holdings's total assets for Q were $8.56M, an increase of 1.06% from the previous quarter. CERO total liabilities were $14.32M for the fiscal quarter, a 2.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.